Novel Candidate Cancer Genes Identified by a Large-scale Cross-species Comparative Oncogenomics Approach

Overview

Journal Cancer Res

Specialty Oncology

Date 2010 Jan 28

PMID 20103622

Citations 26

Authors

Jenny Mattison

Jaap Kool

Anthony G Uren

Jeroen de Ridder

Lodewyk Wessels

Jos Jonkers

Graham R Bignell

Adam Butler

Alistair G Rust

Markus Brosch

Catherine H Wilson

Louise van der Weyden

David A Largaespada

Michael R Stratton

P Andy Futreal

Maarten van Lohuizen

Anton Berns

Lara S Collier

Tim Hubbard

David J Adams

Affiliations

Soon will be listed here.

Abstract

Comparative genomic hybridization (CGH) can reveal important disease genes but the large regions identified could sometimes contain hundreds of genes. Here we combine high-resolution CGH analysis of 598 human cancer cell lines with insertion sites isolated from 1,005 mouse tumors induced with the murine leukemia virus (MuLV). This cross-species oncogenomic analysis revealed candidate tumor suppressor genes and oncogenes mutated in both human and mouse tumors, making them strong candidates for novel cancer genes. A significant number of these genes contained binding sites for the stem cell transcription factors Oct4 and Nanog. Notably, mice carrying tumors with insertions in or near stem cell module genes, which are thought to participate in cell self-renewal, died significantly faster than mice without these insertions. A comparison of the profile we identified to that induced with the Sleeping Beauty (SB) transposon system revealed significant differences in the profile of recurrently mutated genes. Collectively, this work provides a rich catalogue of new candidate cancer genes for functional analysis.

Citing Articles

Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.

Tang Y, Li K, Hu B, Cai Z, Li J, Tao H Cancer Biol Ther. 2022; 23(1):424-438.

PMID: 35816613 PMC: 9275499. DOI: 10.1080/15384047.2022.2094670.

STAT3 roles in viral infection: antiviral or proviral?.

Chang Z, Wang Y, Zhou X, Long J Future Virol. 2020; 13(8):557-574.

PMID: 32201498 PMC: 7079998. DOI: 10.2217/fvl-2018-0033.

DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.

Zheng Y, Hlady R, Joyce B, Robertson K, He C, Nannini D Clin Epigenetics. 2019; 11(1):145.

PMID: 31639042 PMC: 6802191. DOI: 10.1186/s13148-019-0733-y.

Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.

Jafek J, Shakya A, Tai P, Ibarra A, Kim H, Maddox J Exp Hematol. 2019; 76:38-48.e2.

PMID: 31295506 PMC: 7670548. DOI: 10.1016/j.exphem.2019.07.002.

Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.

Vazquez-Arreguin K, Bensard C, Schell J, Swanson E, Chen X, Rutter J PLoS Genet. 2019; 15(5):e1007687.

PMID: 31059499 PMC: 6522070. DOI: 10.1371/journal.pgen.1007687.

References

Sjoblom T, Jones S, Wood L, Parsons D, Lin J, Barber T . The consensus coding sequences of human breast and colorectal cancers. Science. 2006; 314(5797):268-74. DOI: 10.1126/science.1133427. View

Broussard D, Mertz J, Lozano M, Dudley J . Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol. 2002; 76(5):2087-99. PMC: 153816. DOI: 10.1128/jvi.76.5.2087-2099.2002. View

Nichols J, Zevnik B, Anastassiadis K, Niwa H, Chambers I, Scholer H . Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998; 95(3):379-91. DOI: 10.1016/s0092-8674(00)81769-9. View

Collier L, Carlson C, Ravimohan S, Dupuy A, Largaespada D . Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature. 2005; 436(7048):272-6. DOI: 10.1038/nature03681. View

Durkin S, Glover T . Chromosome fragile sites. Annu Rev Genet. 2007; 41:169-92. DOI: 10.1146/annurev.genet.41.042007.165900. View

Kamimura K, Mishima Y, Obata M, Endo T, Aoyagi Y, Kominami R . Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages. Oncogene. 2007; 26(40):5840-50. DOI: 10.1038/sj.onc.1210388. View

Ben-Porath I, Thomson M, Carey V, Ge R, Bell G, Regev A . An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008; 40(5):499-507. PMC: 2912221. DOI: 10.1038/ng.127. View

Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D . High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998; 20(2):207-11. DOI: 10.1038/2524. View

Zender L, Spector M, Xue W, Flemming P, Cordon-Cardo C, Silke J . Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006; 125(7):1253-67. PMC: 3026384. DOI: 10.1016/j.cell.2006.05.030. View

10.

Forbes S, Bhamra G, Bamford S, Dawson E, Kok C, Clements J . The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10:Unit 10.11. PMC: 2705836. DOI: 10.1002/0471142905.hg1011s57. View

11.

de Ridder J, Uren A, Kool J, Reinders M, Wessels L . Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput Biol. 2006; 2(12):e166. PMC: 1676030. DOI: 10.1371/journal.pcbi.0020166. View

12.

Campbell P, Stephens P, Pleasance E, OMeara S, Li H, Santarius T . Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet. 2008; 40(6):722-9. PMC: 2705838. DOI: 10.1038/ng.128. View

13.

Gabriel S . Variation in the human genome and the inherited basis of common disease. Semin Oncol. 2006; 33(6 Suppl 11):S46-9. DOI: 10.1053/j.seminoncol.2006.11.001. View

14.

Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

15.

Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C . DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 2008; 22(11):1439-44. PMC: 2418580. DOI: 10.1101/gad.1672608. View

16.

Dupuy A, Akagi K, Largaespada D, Copeland N, Jenkins N . Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature. 2005; 436(7048):221-6. DOI: 10.1038/nature03691. View

17.

Mullighan C, Goorha S, Radtke I, Miller C, Coustan-Smith E, Dalton J . Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137):758-64. DOI: 10.1038/nature05690. View

18.

Dennis Jr G, Sherman B, Hosack D, Yang J, Gao W, Lane H . DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4(5):P3. View

19.

Wong D, Liu H, Ridky T, Cassarino D, Segal E, Chang H . Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell. 2008; 2(4):333-44. PMC: 2628721. DOI: 10.1016/j.stem.2008.02.009. View

20.

Lenz G, Wright G, Emre N, Kohlhammer H, Dave S, Davis R . Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A. 2008; 105(36):13520-5. PMC: 2533222. DOI: 10.1073/pnas.0804295105. View